News

Filter

Current filters:

OPKO HealthOncology

176 to 185 of 96157 results

Australia participating in EU DCP for evaluation of generic drugs

Australia participating in EU DCP for evaluation of generic drugs

02-09-2014

Under the auspices of the International Generic Drug Regulators Pilot , Australia’s Therapeutic Goods…

AustraliaGenericsRegulation

Australian medical bodies advocate for the government's Medical Research Future Fund

Australian medical bodies advocate for the government's Medical Research Future Fund

02-09-2014

Australian medical bodies are collaborating to advocate for the Medical Research Future Fund (MRFF) proposed…

AustraliaBiotechnologyFinancialMRFF Action GroupPolitics

Drew Young appointed senior vice president of neurology and immunology at EMD Serono

Drew Young appointed senior vice president of neurology and immunology at EMD Serono

02-09-2014

EMD Serono, a subsidiary of Germany's Merck KGaA, has appointed Drew Young as senior vice president of…

BoardroomEMD Serono

Exelixis says cabozantinib failed in Ph III prostate cancer trial

Exelixis says cabozantinib failed in Ph III prostate cancer trial

02-09-2014

US biotech firm Exelixis has posted disappointing top-line results from the final analysis of COMET-1,…

BiotechnologycabozantinibExelixisOncologyResearchSwedish Orphan Biovitrum

Benefit for once-daily Xarelto in the first trial to evaluate prospective use in AF patients undergoing cardioversion

Benefit for once-daily Xarelto in the first trial to evaluate prospective use in AF patients undergoing cardioversion

02-09-2014

German pharma and chemical major Bayer has released results from the X-VeRT* study, demonstrating that…

BayerCardio-vascularPharmaceuticalResearchXarelto

bluebird bio poised to advance gene therapy pipeline

bluebird bio poised to advance gene therapy pipeline

02-09-2014

US clinical-stage biotech firm bluebird bio is advancing a pipeline focused on gene therapy, a rapidly…

Biotechnologybluebird bioCelgene Corp.OncologyRare diseasesResearch

Novo Nordisk pulls out of inflammatory disorders research

Novo Nordisk pulls out of inflammatory disorders research

02-09-2014

Danish diabetes care giant Novo Nordisk says it has decided to discontinue all its R&D activities within…

Anti-Arthritics/RheumaticsInflammatory diseasesNovo NordiskPharmaceutical

176 to 185 of 96157 results

Back to top